4f2a
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
==Crystal structure of cholestryl esters transfer protein in complex with inhibitors== | ==Crystal structure of cholestryl esters transfer protein in complex with inhibitors== | ||
- | <StructureSection load='4f2a' size='340' side='right' caption='[[4f2a]], [[Resolution|resolution]] 3.11Å' scene=''> | + | <StructureSection load='4f2a' size='340' side='right'caption='[[4f2a]], [[Resolution|resolution]] 3.11Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[4f2a]] is a 1 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[4f2a]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4F2A OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4F2A FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=0SF:(2R)-3-{[4-(4-CHLORO-3-ETHYLPHENOXY)PYRIMIDIN-2-YL][3-(1,1,2,2-TETRAFLUOROETHOXY)BENZYL]AMINO}-1,1,1-TRIFLUOROPROPAN-2-OL'>0SF</scene>, <scene name='pdbligand=2OB:CHOLESTERYL+OLEATE'>2OB</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=0SF:(2R)-3-{[4-(4-CHLORO-3-ETHYLPHENOXY)PYRIMIDIN-2-YL][3-(1,1,2,2-TETRAFLUOROETHOXY)BENZYL]AMINO}-1,1,1-TRIFLUOROPROPAN-2-OL'>0SF</scene>, <scene name='pdbligand=2OB:CHOLESTERYL+OLEATE'>2OB</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=FUC:ALPHA-L-FUCOSE'>FUC</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=PCW:1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE'>PCW</scene>, <scene name='pdbligand=PGE:TRIETHYLENE+GLYCOL'>PGE</scene></td></tr> |
- | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4f2a FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4f2a OCA], [https://pdbe.org/4f2a PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4f2a RCSB], [https://www.ebi.ac.uk/pdbsum/4f2a PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4f2a ProSAT]</span></td></tr> | |
- | + | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Disease == | == Disease == | ||
- | [ | + | [https://www.uniprot.org/uniprot/CETP_HUMAN CETP_HUMAN] Defects in CETP are the cause of hyperalphalipoproteinemia type 1 (HALP1) [MIM:[https://omim.org/entry/143470 143470]. Affected individuals show high levels of alpha-lipoprotein (high density lipoprotein/HDL).<ref>PMID:2215607</ref> <ref>PMID:8408659</ref> <ref>PMID:12091484</ref> |
== Function == | == Function == | ||
- | [ | + | [https://www.uniprot.org/uniprot/CETP_HUMAN CETP_HUMAN] Involved in the transfer of insoluble cholesteryl esters in the reverse transport of cholesterol. |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 26: | Line 24: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
- | [[Category: | + | [[Category: Large Structures]] |
- | [[Category: | + | [[Category: Liu S]] |
- | [[Category: | + | [[Category: Qiu X]] |
- | + | ||
- | + | ||
- | + | ||
- | + |
Revision as of 04:29, 7 October 2022
Crystal structure of cholestryl esters transfer protein in complex with inhibitors
|